Journal
ADVANCED HEALTHCARE MATERIALS
Volume 9, Issue 15, Pages -Publisher
WILEY
DOI: 10.1002/adhm.201901794
Keywords
3D bioprinting; bioinks; calcium peroxide; cardiomyocytes; hypoxia; oxygen
Funding
- National Institutes of Health [1R01EB021857, R01GM126571]
- American Heart Association Transformational Project Award [18TPA34230036]
- Swiss National Foundation Postdoctoral Fellowship [P2EZP2_187980]
- TUBITAK-2219 [1059B191700093]
- Swiss National Science Foundation (SNF) [P2EZP2_187980] Funding Source: Swiss National Science Foundation (SNF)
Ask authors/readers for more resources
Cell survival during the early stages of transplantation and before new blood vessels formation is a major challenge in translational applications of 3D bioprinted tissues. Supplementing oxygen (O-2) to transplanted cells via an O(2)generating source such as calcium peroxide (CPO) is an attractive approach to ensure cell viability. Calcium peroxide also produces calcium hydroxide that reduces the viscosity of bioinks, which is a limiting factor for bioprinting. Therefore, adapting this solution into 3D bioprinting is of significant importance. In this study, a gelatin methacryloyl (GelMA) bioink that is optimized in terms of pH and viscosity is developed. The improved rheological properties lead to the production of a robust bioink suitable for 3D bioprinting and controlled O(2)release. In addition, O(2)release, bioprinting conditions, and mechanical performance of hydrogels having different CPO concentrations are characterized. As a proof of concept study, fibroblasts and cardiomyocytes are bioprinted using CPO containing GelMA bioink. Viability and metabolic activity of printed cells are checked after 7 days of culture under hypoxic condition. The results show that the addition of CPO improves the metabolic activity and viability of cells in bioprinted constructs under hypoxic condition.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available